Advertisement

Topics

Immune Pharma's Oncology Subsidiary, Cytovia, Inc., Announces Additional Clinical Trial Results On The Efficacy Of Ceplene In Combination With Low-Dose IL-2 In Patients With Acute Myeloid Leukemia, Recently Published In A Leading Hematology Journal

20:00 EDT 4 Jul 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Immune Pharma's Oncology Subsidiary, Cytovia, Inc., Announces Additional Clinical Trial Results On The Efficacy Of Ceplene In Combination With Low-Dose IL-2 In Patients With Acute Myeloid Leukemia, Recently Published In A Leading Hematology Journal

NEXT ARTICLE

More From BioPortfolio on "Immune Pharma's Oncology Subsidiary, Cytovia, Inc., Announces Additional Clinical Trial Results On The Efficacy Of Ceplene In Combination With Low-Dose IL-2 In Patients With Acute Myeloid Leukemia, Recently Published In A Leading Hematology Journal"

Advertisement
Quick Search
Advertisement
Advertisement